key: cord-0050806-b3gootdn
authors: DeLaroche, Amy M.; Stankovic, Curt; Ehrman, Robert R.; Noble, M.S. Jennifer; Arora, Rajan; Maksimowski, Karolina; Ruffing, Ronald
title: Emergency department screening for multisystem inflammatory syndrome (MIS-C) in children
date: 2020-09-29
journal: Am J Emerg Med
DOI: 10.1016/j.ajem.2020.09.076
sha: c016b2dfb676460fa6085b8503f57a88944d2f70
doc_id: 50806
cord_uid: b3gootdn

nan

Multisystem inflammatory syndrome in children (MIS-C) was defined by the Centers for Disease Control and Prevention (CDC) in May 2020. 1 An approach to the identification of this uncommon yet life-threatening illness among well-appearing febrile children presenting for medical care is urgently needed as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection continuous to affect millions worldwide. 2, 3 Thus, the aims of this report are to:

(1) describe our institutional approach to screening for MIS-C; (2) report the test characteristics of our approach in excluding MIS-C; and (3) provide recommendations for screening for MIS-C among well appearing children with fever.

Screening for MIS-C at an urban, tertiary care pediatric emergency department (PED) located in a geographic area with a high burden of SARS-CoV-2 infections 2 was implemented on May 7, 2020. For well appearing children presenting with fever ≥ 48 hours with rash, gastrointestinal symptoms, or clinical features of Kawasaki Disease, 4 the initial recommended screening laboratory studies include: complete blood count with differential (CBC), comprehensive metabolic panel (CMP), C-reactive protein (CRP), ferritin, d-dimer, and highsensitivity troponin I (troponin). We retrospectively reviewed the PED logs for May 7 to May 31, 2020 to identify patients < 21 years of age with a relevant chief complaint (e.g. fever, diarrhea, rash) who had a ferritin, d-dimer or troponin performed (as CBC, CMP, and CRP are not specific to our screening algorithm). Demographic and clinical characteristics, including final diagnoses, and laboratory values were abstracted by clinicians using a standardized data collection tool and entered into Research Electronic Data Capture (REDCap). 6 J o u r n a l P r e -p r o o f For analysis, patients were dichotomized as MIS-C or not (see Table 1 ). Means/standard deviations, medians/interquartile ranges, or frequencies/95% confidence intervals (CI) were calculated for patient characteristics. Univariate logistic regression (LR) was used to assess the association of clinical data with the primary outcome (non-MIS-C); those with p < 0.1 were assessed for independent association using multivariable LR. Co-linearity of predictors was assessed using variance inflation factor. As our goal was to identify characteristics associated with a low probability of MIS-C, composite predictor variables were created, with candidates selected from the multivariable analysis or "by meaning". Continuous predictors (except age)

were dichotomized with a cut-point determined by Youden's J statistic. Meeting institutional or CDC clinical criteria for screening was also included in the composite variable. Final model selection was based on comparison of Akaike's Information Criteria, area under the receiver operating characteristic curve (AUC), and CI width (narrower considered more clinically informative). Two-tailed significance level was set at 0.05. Statistical analysis was performed using SAS v9.4 (Cary, NC).

Among 2,536 patients presenting during the study period, 196 (8%) were included in the analysis and 12 (0.5%) were categorized as MIS-C. Demographics and screening laboratory results are reported in Table 1 . On multivariable analysis, troponin, d-dimer, ferritin, CRP, and age had significant inverse associations with the primary outcome. Composite laboratory value predictor variables performed differently depending on whether institutional or CDC clinical screening criteria were used. Final models for each, along with independent contribution of age, are presented in Table 2 . J o u r n a l P r e -p r o o f 

Centers for Disease Control and Prevention Emergency Preparedness and Response: multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19)

Multisystem inflammatory syndrome in U.S. children and adolescents

American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals for the American Heart Association

Research electronic data capture (REDCap) -a metadata-driven methodology and workflow process for providing translational research informatics support

ALT (reference range: 7-52 U/L)

Abbreviations: ALT, alanine aminotransferase

PED, pediatric emergency department

PICU, pediatric intensive care unit

multisystem inflammatory syndrome in children; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2

SI conversion factors: To convert hemoglobin to g/L multiply by 10

Eight patients with MIS-C met CDC criteria. Two patients with MIS-C met CDC criteria except for laboratory confirmed SARS-CoV-2 infection or an epidemiological link to SARS-CoV-2. One patient with MIS-C met CDC criteria except for fever